These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34826684)

  • 1. Pectins from various sources inhibit galectin-3-related cardiac fibrosis.
    Pozder Geb Gehlken C; Rogier van der Velde A; Meijers WC; Silljé HHW; Muntendam P; Dokter MM; van Gilst WH; Schols HA; de Boer RA
    Curr Res Transl Med; 2022 Jan; 70(1):103321. PubMed ID: 34826684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modified citrus pectin ameliorates myocardial fibrosis and inflammation via suppressing galectin-3 and TLR4/MyD88/NF-κB signaling pathway.
    Xu GR; Zhang C; Yang HX; Sun JH; Zhang Y; Yao TT; Li Y; Ruan L; An R; Li AY
    Biomed Pharmacother; 2020 Jun; 126():110071. PubMed ID: 32172066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulated galectin-3 is not a critical disease mediator of cardiomyopathy induced by β
    Nguyen MN; Su Y; Kiriazis H; Yang Y; Gao XM; McMullen JR; Dart AM; Du XJ
    Am J Physiol Heart Circ Physiol; 2018 Jun; 314(6):H1169-H1178. PubMed ID: 29424570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified citrus pectin reduces galectin-3 expression and disease severity in experimental acute kidney injury.
    Kolatsi-Joannou M; Price KL; Winyard PJ; Long DA
    PLoS One; 2011 Apr; 6(4):e18683. PubMed ID: 21494626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified citrus pectin stops progression of liver fibrosis by inhibiting galectin-3 and inducing apoptosis of stellate cells.
    Abu-Elsaad NM; Elkashef WF
    Can J Physiol Pharmacol; 2016 May; 94(5):554-62. PubMed ID: 27010252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galectin-3 deficiency ameliorates fibrosis and remodeling in dilated cardiomyopathy mice with enhanced Mst1 signaling.
    Nguyen MN; Ziemann M; Kiriazis H; Su Y; Thomas Z; Lu Q; Donner DG; Zhao WB; Rafehi H; Sadoshima J; McMullen JR; El-Osta A; Du XJ
    Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H45-H60. PubMed ID: 30387702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modified Citrus Pectin Prevents Blood-Brain Barrier Disruption in Mouse Subarachnoid Hemorrhage by Inhibiting Galectin-3.
    Nishikawa H; Liu L; Nakano F; Kawakita F; Kanamaru H; Nakatsuka Y; Okada T; Suzuki H
    Stroke; 2018 Nov; 49(11):2743-2751. PubMed ID: 30355205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The detrimental role of galectin-3 and endoplasmic reticulum stress in the cardiac consequences of myocardial ischemia in the context of obesity.
    Jiménez-González S; Delgado-Valero B; Islas F; Romero-Miranda A; Luaces M; Ramchandani B; Cuesta-Corral M; Montoro-Garrido A; Martínez-Martínez E; Cachofeiro V
    FASEB J; 2024 Jul; 38(14):e23818. PubMed ID: 38989572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of human cancer cell growth and metastasis in nude mice by oral intake of modified citrus pectin.
    Nangia-Makker P; Hogan V; Honjo Y; Baccarini S; Tait L; Bresalier R; Raz A
    J Natl Cancer Inst; 2002 Dec; 94(24):1854-62. PubMed ID: 12488479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of galectin-3 in liver metastasis of colon cancer and the inhibitory effect of modified citrus pectin].
    Huang ZL; Liu HY
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(8):1358-61. PubMed ID: 18753060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Galectin-3 Pathway Prevents Isoproterenol-Induced Left Ventricular Dysfunction and Fibrosis in Mice.
    Vergaro G; Prud'homme M; Fazal L; Merval R; Passino C; Emdin M; Samuel JL; Cohen Solal A; Delcayre C
    Hypertension; 2016 Mar; 67(3):606-12. PubMed ID: 26781273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galectin-3 inhibition attenuates doxorubicin-induced cardiac dysfunction by upregulating the expression of peroxiredoxin-4.
    Tian Y; Lv W; Lu C; Jiang Y; Yang X; Song M
    Can J Physiol Pharmacol; 2020 Oct; 98(10):700-707. PubMed ID: 32516552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic and pharmacological inhibition of galectin-3 prevents cardiac remodeling by interfering with myocardial fibrogenesis.
    Yu L; Ruifrok WP; Meissner M; Bos EM; van Goor H; Sanjabi B; van der Harst P; Pitt B; Goldstein IJ; Koerts JA; van Veldhuisen DJ; Bank RA; van Gilst WH; Silljé HH; de Boer RA
    Circ Heart Fail; 2013 Jan; 6(1):107-17. PubMed ID: 23230309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified citrus pectin inhibited bladder tumor growth through downregulation of galectin-3.
    Fang T; Liu DD; Ning HM; Dan Liu ; Sun JY; Huang XJ; Dong Y; Geng MY; Yun SF; Yan J; Huang RM
    Acta Pharmacol Sin; 2018 Dec; 39(12):1885-1893. PubMed ID: 29769742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein kinase C promotes cardiac fibrosis and heart failure by modulating galectin-3 expression.
    Song X; Qian X; Shen M; Jiang R; Wagner MB; Ding G; Chen G; Shen B
    Biochim Biophys Acta; 2015 Feb; 1853(2):513-21. PubMed ID: 25489662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breaking barriers: How modified citrus pectin inhibits galectin-8.
    Shuai M; Li Y; Guan F; Fu G; Sun C; Ren Q; Wang L; Zhang T
    Food Funct; 2024 May; 15(9):4887-4893. PubMed ID: 38597504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective effects of ginseng pectins on galectin-3-mediated T cell activation and apoptosis.
    Xue H; Zhao Z; Lin Z; Geng J; Guan Y; Song C; Zhou Y; Tai G
    Carbohydr Polym; 2019 Sep; 219():121-129. PubMed ID: 31151509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galectin 3 inhibition attenuates renal injury progression in cisplatin-induced nephrotoxicity.
    Li HY; Yang S; Li JC; Feng JX
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30455396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effect of modified citrus pectin on liver metastases in a mouse colon cancer model.
    Liu HY; Huang ZL; Yang GH; Lu WQ; Yu NR
    World J Gastroenterol; 2008 Dec; 14(48):7386-91. PubMed ID: 19109874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pleiotropic Effects of Modified Citrus Pectin.
    Eliaz I; Raz A
    Nutrients; 2019 Nov; 11(11):. PubMed ID: 31683865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.